On April 3, 2024, TS Nexgen Co., Ltd. closed the transaction. The company announced that it has issued 11,992,619 common shares at an issue price of KRW 542 per share for the gross proceeds of KRW 6,499,999,498. The transaction will include participation from new investor Cisco Bio Investment Fund.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
816 KRW | -4.00% | +0.99% | +30.77% |
1st Jan change | Capi. | |
---|---|---|
+30.77% | 69.55M | |
+47.29% | 25.32B | |
+43.32% | 17.02B | |
+20.64% | 10.04B | |
-8.59% | 8.09B | |
+4.09% | 7.82B | |
+27.13% | 7.7B | |
+150.15% | 6.61B | |
+43.41% | 5.01B | |
+137.13% | 4.53B |
- Stock Market
- Equities
- A043220 Stock
- News TS Nexgen Co., Ltd.
- TS Nexgen Co., Ltd. announced that it has received KRW 6.499999498 billion in funding